| 產(chǎn)品名稱 |
Influenza A virus (H3N2) |
| 商品貨號(hào) |
B162983 |
| Classification |
Orthomyxoviridae, Alphainfluenzavirus |
| Deposited As |
Influenza A virus |
| Agent |
Influenza A virus (H3N2) |
| Strain |
MRC 2 |
| Applications |
Influenza Research |
| Biosafety Level |
2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format |
frozen 1.0 mL per vial |
| Storage Conditions |
-70°C or colder |
| Disclosure |
This material is cited in a US or other Patent and may not be used to
infringe the claims. Depending on the wishes of the Depositor, ATCC may be
required to inform the Patent Depositor of the party to which the material was
furnished. This material may not have been produced or characterized by ATCC. |
| Comments |
Hemagglutinin and neuraminidase antigens identical to strain A/England/42/72, i.e., H(3)N(2) type.
Unrelated to A/PR8/34 (Honi). |
| Effect on Host |
Hemagglutinates chicken RBC and guinea pig RBC. |
| Recommended Host |
SPF embryonated chicken egg (10 to 11 day, intra-allantoic) |
| Growth Conditions |
Temperature: 37°C
Incubation: 2 to 3 days at 37°C with humidity |
| Name of Depositor |
R.I.T. - Recherche et Industrie Therapeutiques |
| U.S. Patent |
|
| U.S. Patent Number |
|
| Source |
Human (recombinant A/England/42/72 and A/PR8/34 influenza strains) |
| References |
Peetermans J. Live influenza virus vaccines and preparation thereof. US Patent 3,953,592 dated Apr 27 1976
|
